Financial News
RAPT Therapeutics, Inc. - Common Stock (NQ: RAPT )
1.200
+0.010
(+0.84%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Press Releases about RAPT Therapeutics, Inc. - Common Stock
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
RAPT Therapeutics Announces $150 Million Private Placement
December 23, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
RAPT Therapeutics Reports Third Quarter 2024 Financial Results
November 12, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
RAPT Therapeutics Reports Second Quarter 2024 Financial Results
August 08, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/60f84371-8ef5-454a-ab60-63e56a837741/small/schall-firm-logo-2-jpg.jpg)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
Via GlobeNewswire
![](https://mms.businesswire.com/media/20240226791131/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
![](https://ml.globenewswire.com/media/0318fcd4-dd76-410b-9459-4f0b2a1c7b40/small/rapt-therapeutics-logo-color-png.png)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.